Page 75 - AN-3-2
P. 75

Advanced Neurology                                             Inflammation in diabetic stroke: Treatment target



            99.  Westendorp  WF,  Vermeij JD, Smith  CJ,  et al.  Preventive   2015;35(5):2133-2145.
                antibiotic therapy in acute stroke patients: A  systematic      doi: 10.1523/JNEUROSCI.4098-14.2015
                review and meta-analysis of individual patient data of
                randomized controlled trials. Eur Stroke J. 2021;6(4):385-394.  110.  Thapa R, Afzal O, Alfawaz Altamimi AS, et al. Galangin
                                                                   as an inflammatory response modulator: An updated
                doi: 10.1177/23969873211056445                     overview and therapeutic potential.  Chem Biol Interact.
            100.  Wen H, Weymann KB, Wood L, Wang QM. Inflammatory   2023;378:110482.
                signaling in post-stroke fatigue and depression. Eur Neurol.      doi: 10.1016/j.cbi.2023.110482
                2018;80(3-4):138-148.
                                                               111.  Xu H, Wang E, Chen F, Xiao J, Wang M. Neuroprotective
                doi: 10.1159/000494988                             phytochemicals  in  experimental  ischemic  stroke:
            101.  Caiaffo V, Oliveira BD, de Sa FB, Evencio Neto J. Anti-  Mechanisms and potential clinical applications. Oxid Med
                inflammatory, antiapoptotic, and antioxidant activity of   Cell Longev. 2021;2021:6687386.
                fluoxetine. Pharmacol Res Perspect. 2016;4(3):e00231.     doi: 10.1155/2021/6687386
                doi: 10.1002/prp2.231                          112.  Zhu T, Wang L, Feng Y, Sun G, Sun X. Classical active
            102.  Schneider CL, Prentiss EK, Busza A, Williams ZR,   ingredients and extracts of Chinese herbal medicines:
                Mahon  BZ, Sahin B. FLUORESCE: A  pilot randomized   Pharmacokinetics, pharmacodynamics, and molecular
                clinical  trial  of  fluoxetine  for  vision  recovery  after  acute   mechanisms for ischemic stroke.  Oxid  Med  Cell  Longev.
                ischemic stroke. J Neuroophthalmol. 2023;43(2):237-242.  2021;2021:8868941.
                doi: 10.1097/WNO.0000000000001654                  doi: 10.1155/2021/8868941
            103.  Knox MG, Demaerschalk BM, Alcott SB, Marks LA,   113.  Zhou P, Du S, Zhou L, et al. Tetramethylpyrazine2’Osodium
                Wingerchuk DM, O’Carroll CB. Does the initiation of fluoxetine   ferulate  provides  neuroprotection  against
                postacute stroke result in improved functional recovery?:   neuroinflammation and brain injury in MCAO/R rats
                A critically appraised topic. Neurologist. 2021;26(3):112-115.  by suppressing TLR-4/NF-kappaB signaling pathway.
                                                                   Pharmacol Biochem Behav. 2019;176:33-42.
                doi: 10.1097/NRL.0000000000000314
                                                                   doi: 10.1016/j.pbb.2018.08.010
            104.  Li N, Hua J. Interactions between mesenchymal
                stem cells and the immune system.  Cell  Mol  Life  Sci.   114.  Tsai FJ, Ho TJ, Cheng CF, et al. Effect of Chinese herbal
                2017;74(13):2345-2360.                             medicine on stroke patients with type  2 diabetes.
                                                                   J Ethnopharmacol. 2017;200:31-44.
                doi: 10.1007/s00018-017-2473-5
                                                                   doi: 10.1016/j.jep.2017.02.024
            105.  He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative
                stress, inflammation, and autophagy: Potential targets of   115.  Ritzel RM, Lai YJ, Crapser JD,  et al. Aging alters the
                mesenchymal stem cells-based therapies in ischemic stroke.   immunological response to ischemic stroke.  Acta
                Front Neurosci. 2021;15:641157.                    Neuropathol. 2018;136(1):89-110.
                doi: 10.3389/fnins.2021.641157                     doi: 10.1007/s00401-018-1859-2
            106.  Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal   116.  Buga AM, Di Napoli M, Popa-Wagner A. Preclinical models
                stem cell therapy for ischemic stroke: A  look into   of stroke in aged animals with or without comorbidities: Role
                treatment mechanism and therapeutic potential. J Neurol.   of neuroinflammation. Biogerontology. 2013;14(6):651-662.
                2021;268(11):4095-4107.                            doi: 10.1007/s10522-013-9465-0
                doi: 10.1007/s00415-020-10138-5                117.  Yamashiro K, Kurita N, Urabe T, Hattori N. Role
            107.  Cordeau P Jr., Lalancette-Hebert M, Weng YC, Kriz J. Live   of the gut microbiota in stroke pathogenesis and
                imaging  of  neuroinflammation  reveals  sex  and  estrogen   potential therapeutic implications.  Ann Nutr Metab.
                effects on astrocyte response to ischemic injury.  Stroke.   2021;77 Suppl 2(Suppl 2):36-44.
                2008;39(3):935-942.                                doi: 10.1159/000516398
                doi: 10.1161/STROKEAHA.107.501460              118.  Delrue C, Delanghe JR, Speeckaert MM. The role of sRAGE
            108.  Chernykh ER, Shevela EY, Starostina NM,  et  al. Safety   in cardiovascular diseases. Adv Clin Chem. 2023;117:53-102.
                and therapeutic  potential of  M2 macrophages  in  stroke      doi: 10.1016/bs.acc.2023.08.005
                treatment. Cell Transplant. 2016;25(8):1461-1471.
                                                               119.  Baker EW, Kinder HA, West FD. Neural stem cell therapy
                doi: 10.3727/096368915X690279                      for stroke: A  multimechanistic approach to restoring
                                                                   neurological function. Brain Behav. 2019;9(3):e01214.
            109.  Doyle KP, Quach LN, Sole M, et al. B-lymphocyte-mediated
                delayed cognitive impairment following stroke. J Neurosci.      doi: 10.1002/brb3.1214


            Volume 3 Issue 2 (2024)                         14                               doi: 10.36922/an.1694
   70   71   72   73   74   75   76   77   78   79   80